Ann: Key milestone - First patients enrol into wheezo RPM program, page-7

Well I would have thought not, but it did move up so I guess I'm wrong.
The reason I said I didn't think so is because market sentiment with this company and the other non proven companies has been down or flat and this statement only says we made another small step forward. Not when the cash will flow, which we have so all been waiting on and maybe waiting a while yet while these trials complete.
Personally I'm a bit worried that the Australian market isn't running with this technology. If it is a good product why isn't it charging ahead here, because if it was good it would do well everywhere.